Testing effectiveness (Phase 2)Study completedNCT01970501
What this trial is testing
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
Who this might be right for
Current or Recent History of Atrial Fibrillation
ARCA Biopharma, Inc. 267